Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics

  • Conde, João
  • Hernández, Yulán
  • Tian, Furong
  • Baptista, Pedro V.
  • Tortiglione, Claudia
  • Fuente, Jesús M. de la
RNAi has always captivated scientists due to its tremendous power to modulate the phenotype of living organisms. This natural and powerful biological mechanism can now be harnessed to downregulate specific gene expression in diseased cells, opening up endless opportunities. Since most of the conventional siRNA delivery methods are limited by a narrow therapeutic index and significant side and off-target effects, we are now in the dawn of a new age in gene therapy driven by nanotechnology vehicles for RNAi therapeutics. Here, we outlook the >do's and dont's> of the inorganic RNAi nanomaterials developed in the last 15 years and the different strategies employed are compared and scrutinized, offering important suggestions for the next 15., This work has been funded by ERANET-NANOSCIERA NANOTRUCK project. JC acknowledges Marie Curie International Outgoing Fellowship (FP7-PEOPLE-2013-IOF, project no. 626386). JMF acknowledges SAF2014-54763-C2-2-R project (Spanish Government), European Regional and Social Development Funds, Aragón Autonomous Government (DGA) through Research Groups and ERC-Starting Grant 239931-NANOPUZZLE., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?

  • Conde, João
  • Tian, Furong
  • Fuente, Jesús M. de la
  • Baptista, Pedro V.
JC acknowledges Marie Curie International Outgoing Fellowship and Funding (FP7-PEOPLE-2013-IOF, Project 626386)., Peer reviewed, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine

  • Conde, João
  • Dias, Jorge T.
  • Grazú, Valeria
  • Moros, María
  • Baptista, Pedro V.
  • Fuente, Jesús M. de la
In the last 30 years we have assisted to a massive advance of nanomaterials in material science. Nanomaterials and structures, in addition to their small size, have properties that differ from those of larger bulk materials, making them ideal for a host of novel applications. The spread of nanotechnology in the last years has been due to the improvement of synthesis and characterization methods on the nanoscale, a field rich in new physical phenomena and synthetic opportunities. In fact, the development of functional nanoparticles has progressed exponentially over the past two decades. This work aims to extensively review 30 years of different strategies of surface modification and functionalization of noble metal (gold) nanoparticles, magnetic nanocrystals and semiconductor nanoparticles, such as quantum dots. The aim of this review is not only to provide in-depth insights into the different biofunctionalization and characterization methods, but also to give an overview of possibilities and limitations of the available nanoparticles., João Conde acknowledges Marie Curie International Outgoing Fellowship (FP7-PEOPLE-2013-IOF, Project no. 626386). Pedro V. Baptista thanks CIGMH/FCT/MCES (PEst-OE/SAU/UI0009/2011-14). Jesus M. de la Fuente thanks MAT2011-26851-C02-01, Fondo Social Europeo, ERC-Starting Grant 239931-NANOPUZZLE, CDTI-INMUNOSWING, Shanghai 100 People Plan and ARAID for financial support., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Otros (Other)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?

  • Conde, J.
  • Tian, F.R.
  • de la Fuente, J.M.
  • Baptista, P.V.
  • Baptista, P.
According to the National Cancer Institute, in 2015 an estimated of 1.7 million new cases of cancer will be diagnosed only in the United States and around 600, 000 people will die from the disease. The most common type of cancer is breast cancer, with more than 234, 000 new cases expected in the United States in 2015. The next most common cancers are prostate cancer and lung cancer.After a quarter of century of rapid technological advances, research has revealed the complexity of cancer, a disease intimately related to the dynamic transformation of the genome. These transformations trigger a range of modification to cell processes and molecular events that initiate and promote tumor genesis and progression, then local invasion and metastasis, i.e., the hallmarks of cancer development. These alterations may cause a wide scope of “diseases” that share similar molecular patterns that cause transformation and malignancy. Each of this stepwise evolution of the initial molecular event drives abnormal growth and loss of differentiation that ultimately causes tissue and organ failure. The initial molecular event may lay within the erroneous expression of a given gene, epigenetic modification and/or sporadic mutations occurring on genomic DNA during the life span of organisms. Each and every one of these molecular events may be evaluated and used as diagnostics biomarker and therapeutic target. For example, therapy action may target a mutated gene and silence its expression so as to avoid erroneous protein expression that mutates cell function. However, the full understanding of the molecular onset of this disease is still far from achieved and the search for mechanisms of treatment will follow closely...